A·S·A·P Co-pay Program: Skytrofa

Funded
About
The A·S·A·P Co-pay Program: Skytrofa offers significant financial support for eligible patients requiring the Skytrofa medication. This program helps commercially insured patients lower their out-of-pocket expenses, allowing them to pay as little as $5 per monthly prescription with a maximum benefit of up to $6000 annually. The A·S·A·P Co-pay Program: Skytrofa is exclusive to patients with private insurance in the United States and territories and excludes those with state or federally funded insurance plans.
Insurance requirements: Commercially insured
As low as: $5 per mo
Enrollment Forms
Enrollment Form
Benefits
$6000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible commercially insured patients may pay as little as $5 per monthly prescription
Maximum benefit of up to $6000 per calendar year
HCP should fax or email completed Statement of Medical Necessity Form to: (Fax) 8884360193 or (Email) info@ascendissupport.com
For assistance or additional information, call 8444427236, Monday Friday, 8 AM to 8 PM ET
Other Programs

HealthWell: Growth Hormone Deficiency

Commercially Insured
Medicare / Medicaid
Max Saving: $2800/year*

NORD: Neurofibromatosis Type 1 (NF1) (Premium & Copay)

Commercially Insured
Medicare / Medicaid
Other Tools for Skytrofa